Pilsicainide-induced coronary vasospasm in a patient with Brugada-type electrocardiogram.
暂无分享,去创建一个
A. Goda | A. Koike | T. Aizawa | T. Yamashita | H. Kirigaya | H. Itoh | L. Fu | Takeshi Kato | K. Sagara
[1] H. Morita,et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. , 2003, Journal of the American College of Cardiology.
[2] H. Morita,et al. Risk stratification for asymptomatic patients with Brugada syndrome. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[3] R. Hauer,et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. , 2002, Circulation.
[4] Y. Aizawa,et al. Class I Antiarrhythmic Drug and Coronary Vasospasm‐Induced T Wave Alternans and Ventricular Tachyarrhythmia in a Patient with Brugada Syndrome and Vasospastic Angina , 2002, Journal of cardiovascular electrophysiology.
[5] Y. Aizawa,et al. Vasospastic Angina Accompanied by Brugada‐Type Electrocardiographic Abnormalities , 2001, Journal of cardiovascular electrophysiology.
[6] J. Towbin,et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.
[7] C. Antzelevitch,et al. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. , 1999, Circulation.
[8] E. Itoh,et al. A case of vasospastic angina presenting Brugada-type ECG abnormalities. , 1999, Japanese circulation journal.
[9] G. Breithardt,et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.
[10] J. Brugada,et al. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.